Consumer watchdog blasts FDA delay on recall
Consumer Rights
A consumer watchdog group scolded the Food and Drug Administration Thursday for taking weeks to evaluate the latest problem with Baxter's drug pumps, which have been plagued by safety issues for years.
In January, Baxter International sent a warning to customers about issues with its Colleague infusion pumps that could cause them to stop pumping and overheat. On Wednesday the company said the FDA classified the announcement as a Class I recall, its most severe warning. The classification applies to problems that can cause "serious adverse health consequences or death."
Public Citizen's Dr. Sidney Wolfe blasted the agency in a letter Thursday for not moving faster.
"Why did it take the FDA 47 days, almost 7 weeks ... to decide that this problem was serious enough to merit being classified as a Class I recall?" Wolfe wrote in a letter to acting FDA Commissioner Dr. Frank Torti.
FDA's classification has limited real-world impact. Baxter's products are not actually being called off the market, but the serious warning is necessary because malfunctions with the devices can be fatal.
Related listings
-
S. Indiana city's mayor defends rental ordinance in court
Consumer Rights 09/04/2017The mayor of a southern Indiana city is defending a rental inspection ordinance that’s resulted in thousands of dollars in fines against property owners and is the subject of a lawsuit.Charlestown Mayor Bob Hall testified during Friday’s ...
-
Ohio Supreme Court justice backs legalizing marijuana
Consumer Rights 07/23/2017An Ohio Supreme Court justice who’s mulling a run for governor thinks it’s time for the state to decriminalize marijuana.Justice William O’Neill, the lone Democrat holding an Ohio statewide office, said making marijuana legal is wor...
-
High Court ruling may hurt claims of talc link to cancer
Consumer Rights 06/23/2017A Supreme Court ruling this week could have a "chilling effect" on the many lawsuits filed in St. Louis claiming talcum powder causes a deadly form of cancer in women, including cases under appeal in which stricken women and their survivors have been...